Request Deal Involvement
Mereo BioPharma and OncoMed announced a $57.4m merger.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Cantor Fitzgerald
brokers
RBC Capital Markets
pr advisors
FTI Consulting
financial advisors
Evercore
pr advisors
Burns McClellan
brokers
Cantor Fitzgerald
legal advisors
Davis Polk & Wardwell
financial advisors
Leerink Partners
legal advisors
Latham & Watkins
or
Principals
bidder
MEREO BIOPHARMA GROUP PLC
target
ONCOMED PHARMACEUTICALS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite